Skip to content
Governance Register

← US public companies

Rain Therapeutics Inc.

SEC CIK 1724979 · RAIN · last insider filing 2024-02-02

Directors (from insider filings)

NameCapacity as filedFilings
BVF Partners L P/IL Director filed 2021 - 2024
BVF INC/IL Director filed 2021 - 2024
Biotechnology Value Fund II LP Director filed 2021 - 2024
Lampert Mark N Director filed 2021 - 2024
Biotechnology Value Trading Fund OS LP Director filed 2021 - 2024
BVF Partners OS Ltd. Director filed 2021 - 2024
BVF I GP LLC Director filed 2021 - 2024
BVF II GP LLC Director filed 2021 - 2024
BVF GP Holdings LLC Director filed 2021 - 2024
Biotechnology Value Fund L P Director filed 2021 - 2024
Berger Franklin M Director filed 2021 - 2024
Nguyen Tran Director filed 2021 - 2024
Davis Aaron I. Director filed 2021 - 2024
Radovich Peter Director filed 2021 - 2024
Wolff Stefani Director filed 2021 - 2024
Hrustanovic Gorjan Director filed 2021 - 2024
Vellanki Avanish Director · President and CEO filed 2021 - 2024
Boxer Capital, LLC Director filed 2021 - 2023
Chen Bihua Director filed 2021 - 2021
MVA Investors, LLC Director filed 2021 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Doebele Robert See Remarks filed 2021 - 2024
Atkisson Erik General Counsel and CCO filed 2023 - 2024
Bruce Josephine Principal Fin. & Acc. Officer filed 2023 - 2023
Bryce Richard Paul Chief Medical Officer filed 2021 - 2023
Cabatuan Nelson VP of Finance & Admin filed 2021 - 2023

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.